Therapeutic uses of compounds with combined sert, 5-HT3 and 5-HT1A activity
- 专利权人:
- H. LUNDBECK A/S;TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.
- 发明人:
- DRAGHEIM, MARIANNE,BATRA, ANEIL,MOORE, NICHOLAS,CHON, JIN
- 申请号:
- DK08850935
- 公开号:
- DK2219647T3
- 申请日:
- 2008.11.12
- 申请国别(地区):
- DK
- 年份:
- 2012
- 代理人:
- 摘要:
- New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity
- Therapeutic Uses of Compounds Having Combined SERT, 5-HT3 and 5-HT1A Activity
- Therapeutic Uses of Compounds Having Combined SERT, 5-HT3 and 5-HT1A Activity
- Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1A activity
- THERAPEUTIC USES OF COMPOUNDS HAVING COMBINED SERT, 5-HT3 AND 5-HT1A ACTIVITY